Torbjørn Bjerke
Founder at Arctic Asset Management AS (Sweden)
Net worth: 523 803 $ as of 2024-04-29
Network origin in Torbjørn Bjerke first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
University of Aarhus
49
| College/University | Other Consumer Services | 49 |
| Public Company | Pharmaceuticals: Major | 45 | |
| Public Company | Financial Conglomerates | 21 | |
| Public Company | Trucking | 20 | |
| Public Company | Pharmaceuticals: Major | 17 | |
11
| Public Company | Pharmaceuticals: Major | 11 |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna.
10
| Operating Division | Investment Managers | 10 |
| Public Company | Biotechnology | 7 | |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Arctic Asset Management AS (Sweden)
 Arctic Asset Management AS (Sweden) Investment ManagersFinance Arctic Asset Management AS (Sweden) (AAM-Sweden) is the Sweden-based investment management arm of Arctic Asset Management AS, ultimately owned by Arctic Securities AS in Norway. The firm was founded in 2016 and is headquartered in Stockholm. AFM-Sweden manages portfolio of Nordic equities, Nordic fixed income and Global Life Science – through mutual funds and discretionary mandates for institutional clients, family offices, investment companies and private clients.
3
| Operating Division | Investment Managers | 3 |
Biothea Pharma, Inc.
 Biothea Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Biothea Pharma, Inc. is an American biotechnology company that operates in the field of pharmaceuticals. The private company was founded by John F. Vavricka. Marina S. Bozilenko has been the CEO of the company since 2021.
3
| Private Company | Miscellaneous Commercial Services | 3 |
TXP Pharma AG (Switzerland)
 TXP Pharma AG (Switzerland) Pharmaceuticals: MajorHealth Technology Part of SynAct Pharma AB, TXP Pharma AG (Switzerland) engages in researching and developing pharmaceutical drugs for the treatment of autoimmune and inflammatory diseases. The company is based in Baar, Switzerland. TXP Pharma AG (Switzerland was acquired by SynAct Pharma AB from GoodWind Holding GmbH on January 16, 2023 for $264.94 million.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Torbjørn Bjerke via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree | |
| Karolinska Institutet | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Doctorate Degree Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal | |
| Copenhagen Business School | College/University | Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree Masters Business Admin | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Human Resources Officer Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Public Communications Contact Chief Investment Officer Chief Executive Officer Director/Board Member | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
| SANA AB | Biotechnology | Founder Director/Board Member Corporate Officer/Principal | |
| ACTIVE BIOTECH AB | Biotechnology | Director/Board Member Director/Board Member Chairman | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal | |
| TXP Pharma GmbH | Chief Executive Officer Founder Corporate Officer/Principal | ||
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chairman Director/Board Member Chief Tech/Sci/R&D Officer | |
| Imperial College London | College/University | Corporate Officer/Principal Graduate Degree Doctorate Degree | |
Sophion Bioscience A/S
 Sophion Bioscience A/S Medical SpecialtiesHealth Technology Sophion Bioscience A/S develops, manufactures and markets instruments and supplies automated patch clamping. It develops throughput patch clamp solutions for functional characterization of living cells. The firm products are used in pharmaceutical and biotech companies around the world. The company was founded in July 2007 and is headquartered in Ballerup, Denmark. | Medical Specialties | Corporate Officer/Principal Chairman Director/Board Member | |
Gesynta Pharma AB
 Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer Founder | |
| MEDIVIR AB | Pharmaceuticals: Major | Director/Board Member Chairman Chief Tech/Sci/R&D Officer | |
| LYSOGENE | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Akinion Pharmaceuticals AB
 Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
KDev Oncology AB
 KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services KDev Oncology AB offers research and development of new cancer treatments. It provides know-how in the field of oncology. The company was founded by David Jern on July 14, 2005 and is headquartered in Solna, Sweden. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
BPIFrance Investissement SAS
 BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development. | Investment Managers | Private Equity Analyst Private Equity Investor | |
| BAXTER INTERNATIONAL INC. | Medical Specialties | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Galderma International SAS
 Galderma International SAS Pharmaceuticals: MajorHealth Technology Galderma SA develops and markets therapeutic and aesthetic solutions for dermatology. It provides medical dermatological solutions for acne, rosacea, psoriasis and other steroid-responsive dermatoses, onychomycosis, pigmentary disorders, skin cancer and medical aesthetic and corrective solutions for skin senescence. The company was founded in 1981 and is headquartered in Paris, France. | Pharmaceuticals: Major | General Counsel Director of Finance/CFO | |
Avilex Pharma ApS
 Avilex Pharma ApS Pharmaceuticals: MajorHealth Technology Avilex Pharma ApS develops and produces drugs to treat brain damage with the uses of dimeric ligands. It also develops novel inhibitors to target a range of unmet medical needs. The firm uses dimeric ligands that targets intracellular with unprecedented potency. The company was founded by Kristian Strømgaard and Anders Bach on December 27, 2012 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chairman Chairman | |
| University of Uppsala | College/University | Doctorate Degree Graduate Degree | |
| PIXIUM VISION | Medical Specialties | Director/Board Member Director/Board Member | |
| NUNAMINERALS A/S | Precious Metals | Chief Executive Officer Director/Board Member | |
Dilafor AB
 Dilafor AB Pharmaceuticals: MajorHealth Technology Dilafor AB develops pharmaceutical products from heparin derivatives with low anticoagulant activity. It investigates document and exploits the pharmacological properties of derivatives in the field of obstetrics. The company was founded by Gunvor Ester Ekman-Ordeberg, Hans-Peter Ekre, Per-Olov Eriksson, Per Giléus, Kjell Gunnarsson, Erik Yngve Holmer, Göran Kvist, Ulf Lindahl, Anders Malmström, Tore Mellstrand, Johan Rasin, and Mats Wahlgren in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Founder | |
KDev Investments AB
 KDev Investments AB BiotechnologyHealth Technology KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and manages investments of companies in the fields of medicine. Its portfolio will include both early and clinical stage pharmaceutical assets, as well as some technology assets. The company was founded on January 10, 2012 and is headquartered in Solna, Sweden. | Biotechnology | Director/Board Member Director/Board Member | |
Disruptive Materials AB
 Disruptive Materials AB Chemicals: Major DiversifiedProcess Industries Disruptive Materials AB manufactures mesoporous magnesium carbonate. It focuses on commercializing the material Upsalite that can be used in applications such as desiccant for humidity control, pharmaceutics, adsorbent for waste handling, thermal and acoustic insulation, cosmetics, adsorbent in ink jet paper,and bio material applications. The company was founded by Johan A. V. Gómez de la Torre, Maria Strømme, Lars-Erik Mattias Karls, and Sara Kristina Frykstrand Ångström in December 2011 and is headquartered in Uppsala, Sweden. | Chemicals: Major Diversified | Director/Board Member Director/Board Member | |
Royal Swedish Academy of Engineering Sciences
 Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| ORSTED A/S | Electric Utilities | Director/Board Member Corporate Officer/Principal | |
Asceneuron SA
 Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Financial Conglomerates | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| VESTAS WIND SYSTEMS A/S | Electrical Products | Director of Finance/CFO Chief Executive Officer | |
Medtronic CoreValve LLC
 Medtronic CoreValve LLC Medical SpecialtiesHealth Technology Medtronic CoreValve LLC develops transcatheter technologies for failing aortic heart valves. Its proprietary ReValving System allows both percutaneous (PAVR) and transapical aortic valve replacement (TAVR) and is intended to provide an alternative to open-heart surgery. The company was founded by Jacques Seguin in 2001 and is located in Irvine, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
| University of Lund | College/University | Corporate Officer/Principal Graduate Degree | |
| DEMANT A/S | Medical Specialties | Director of Finance/CFO Director/Board Member | |
| AURIGA INDUSTRIES A/S | Chemicals: Agricultural | Director of Finance/CFO Director/Board Member | |
Rambøll Gruppen A/S
 Rambøll Gruppen A/S Engineering & ConstructionIndustrial Services Rambøll Gruppen A/S provides engineering, design, and consultancy services. It offers services in the areas of buildings, transportation, water, environment and health, energy, oil and gas, telecom, planning and urban design, and management consulting. The company was founded by Børge Johannes Rambøll and Johan Georg Hannemann on October 15, 1945 and is headquartered in Copenhagen, Denmark. | Engineering & Construction | Corporate Officer/Principal Director/Board Member | |
| CERENO SCIENTIFIC AB | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Mindway AI ApS
 Mindway AI ApS Information Technology ServicesTechnology Services Mindway AI ApS operates as a software company, which engages in the development of technical solutions for gambling purposes. Its artificial intelligence system works with betting operators, platform providers, regulators, and governments to apply early detection and intervention for safer gambling and gaming activities. The company was founded by Kim Mouridsen and is headquartered in Aarhus, Denmark. | Information Technology Services | Director/Board Member Chief Executive Officer | |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | General Government | General Counsel Corporate Officer/Principal |
Statistics
International
| Sweden | 20 |
| Denmark | 18 |
| France | 6 |
| United States | 5 |
| Switzerland | 3 |
Sectoral
| Health Technology | 26 |
| Consumer Services | 7 |
| Commercial Services | 6 |
| Finance | 5 |
| Process Industries | 4 |
Operational
| Director/Board Member | 613 |
| Corporate Officer/Principal | 217 |
| Chairman | 168 |
| Independent Dir/Board Member | 134 |
| Chief Executive Officer | 85 |
Most connected contacts
| Insiders | |
|---|---|
| Peter Hutt | 69 |
| Johan Rutger Christenson | 35 |
| Peter Sjöstrand | 35 |
| Bo Jesper Hansen | 34 |
| Michael Wilhelm Rosenlew | 32 |
| Michael Shalmi | 30 |
| Michel de Rosen | 28 |
| Jeppe Øvlesen | 27 |
| Jørgen Drejer | 26 |
| Chahra Khaoua Epouse Louafi | 26 |
| Flemming Heise Pedersen | 24 |
| Rafaèle Elisabeth Tordjman | 23 |
| Lise Kingo | 23 |
| Thomas Hofman-Bang | 22 |
| Gunilla Anders Ekström | 22 |
- Stock Market
- Insiders
- Torbjørn Bjerke
- Company connections
